Cargando…
Prevalence and global trends of polypharmacy in patients with chronic liver disease: A systematic review and meta-analysis
Despite its central role in drug metabolism, the exact prevalence estimates and factors affecting global trends of polypharmacy in patients with chronic liver disease (CLD) have remained unexamined. The aim of this systematic review and meta-analysis is to estimate the prevalence of polypharmacy in...
Autores principales: | Danjuma, Mohammed Ibn-Mas’ud, Naseralallah, Lina, Ansari, Soubiya, Al Shebly, Rafal, Elhams, Mohammed, AlShamari, Manwa, Kordi, Ahmad, Fituri, Nuha, AlMohammed, Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174406/ https://www.ncbi.nlm.nih.gov/pubmed/37171329 http://dx.doi.org/10.1097/MD.0000000000032608 |
Ejemplares similares
-
What is polypharmacy in people living with HIV/AIDS? A systematic review
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2022) -
Prevalence and global trends of polypharmacy in patients with chronic kidney disease: A systematic review and meta-analysis
por: Naseralallah, Lina, et al.
Publicado: (2023) -
Critical care tele‐pharmacy services during COVID‐19 pandemic: A qualitative exploration of healthcare practitioners' perceptions
por: Isleem, Nour, et al.
Publicado: (2022) -
An investigation into the avoidability of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2021) -
Novel biomarkers for potential risk stratification of drug induced liver injury (DILI): A narrative perspective on current trends
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2019)